← USPTO Patent Applications

SUSTAINED-RELEASE PHARMACEUTICAL COMPOSITION OF SIVELESTAT OR SALT THEREOF AND PREPARATION METHOD THEREOF

Application US20260076936A1 Kind: A1 Mar 19, 2026

Assignee

Beijing Tide Pharmaceutical Co., Ltd.

Inventors

Yuhang SUN, Zhibing ZHANG, Deyue FENG, Yunna DING, Yajing FAN, Yun WU, Leling GAN

Abstract

The present disclosure relates to the field of pharmaceutics and particularly provides a sustained-release pharmaceutical composition of sivelestat and a preparation method therefor. The pharmaceutical composition included sivelestat and a phospholipid. The present disclosure uses sivelestat, which is poorly soluble in water, as an active ingredient and the phospholipid as a stabilizer. Particles of sivelestat have excellent aerodynamic performance, good stability, a small amount of auxiliary materials, and a simple preparation process. After inhalation, the drug stays in the lungs for a long time and has a good sustained-release effect and a good industrial production prospect.

CPC Classifications

A61K 31/24 A61K 9/0075 A61K 9/1617 A61K 9/1623 A61K 9/1635 A61K 9/167 A61K 9/1682

Filing Date

2025-09-12

Application No.

19326926